Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,758,377
  • Shares Outstanding, K 65,103
  • Annual Sales, $ 1,542 M
  • Annual Income, $ 233,560 K
  • EBIT $ 311 M
  • EBITDA $ 385 M
  • 60-Month Beta -0.11
  • Price/Sales 3.14
  • Price/Cash Flow 11.66
  • Price/Book 4.53

Options Overview Details

View History
  • Implied Volatility 51.31% (-2.73%)
  • Historical Volatility 44.47%
  • IV Percentile 51%
  • IV Rank 28.73%
  • IV High 98.35% on 11/05/25
  • IV Low 32.35% on 05/15/25
  • Expected Move (DTE 17) 4.58 (6.03%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 55
  • Volume Avg (30-Day) 318
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 8,851
  • Open Int (30-Day) 9,679
  • Expected Range 71.37 to 80.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.03
  • Number of Estimates 5
  • High Estimate $1.11
  • Low Estimate $0.95
  • Prior Year $1.30
  • Growth Rate Est. (year over year) -20.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.33 +5.28%
on 03/06/26
84.38 -9.75%
on 03/11/26
+1.24 (+1.66%)
since 02/27/26
3-Month
63.37 +20.17%
on 01/20/26
84.38 -9.75%
on 03/11/26
+9.44 (+14.15%)
since 12/26/25
52-Week
47.25 +61.16%
on 08/06/25
108.91 -30.08%
on 05/02/25
-20.01 (-20.81%)
since 03/28/25

Most Recent Stories

More News
3 Russell 2000 Stocks We’re Skeptical Of

3 Russell 2000 Stocks We’re Skeptical Of

LNTH : 75.85 (+3.78%)
KTB : 70.29 (+6.15%)
GATX : 170.74 (+2.13%)
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

BEDFORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians...

LNTH : 75.85 (+3.78%)
3 Reasons to Sell LNTH and 1 Stock to Buy Instead

3 Reasons to Sell LNTH and 1 Stock to Buy Instead

LNTH : 75.85 (+3.78%)
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

LNTH : 75.85 (+3.78%)
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines the diagnostic performance of PYLARIFY ® (piflufolastat F 18) with the potential for larger batches and greater...

LNTH : 75.85 (+3.78%)
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC (“KSF”), announces that KSF has commenced an investigation into...

LNTH : 75.85 (+3.78%)
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®

BEDFORD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling...

LNTH : 75.85 (+3.78%)
Lantheus Holdings: Q4 Earnings Snapshot

Lantheus Holdings: Q4 Earnings Snapshot

LNTH : 75.85 (+3.78%)
Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations

Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations

LNTH : 75.85 (+3.78%)
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Worldwide revenue of $406.8 million and $1.54 billion for the fourth quarter and full year 2025 GAAP fully diluted earnings per share of $0.82 and $3.41 for the fourth quarter and full year 2025 Adjusted...

LNTH : 75.85 (+3.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations,...

See More

Key Turning Points

3rd Resistance Point 76.36
2nd Resistance Point 75.42
1st Resistance Point 74.25
Last Price 75.85
1st Support Level 72.15
2nd Support Level 71.21
3rd Support Level 70.04

See More

52-Week High 108.91
Fibonacci 61.8% 85.36
Fibonacci 50% 78.08
Last Price 75.85
Fibonacci 38.2% 70.80
52-Week Low 47.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.